JPS615012A - Spreading plaster - Google Patents
Spreading plasterInfo
- Publication number
- JPS615012A JPS615012A JP11944084A JP11944084A JPS615012A JP S615012 A JPS615012 A JP S615012A JP 11944084 A JP11944084 A JP 11944084A JP 11944084 A JP11944084 A JP 11944084A JP S615012 A JPS615012 A JP S615012A
- Authority
- JP
- Japan
- Prior art keywords
- vinyl acetate
- plaster
- added
- skin
- adhesivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
【発明の詳細な説明】
本発明は貼付剤、特にプラスター剤(硬膏剤)の改良に
関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to improvements in patches, particularly plasters.
プラスター剤は、比較的水分含量が低い天然ゴム又は合
成ゴム等の高分子を基剤として用いるものであるが、天
然ゴム又はスチレン、イソブチレン等のゴム質を用いた
プラスター剤の製造法は文献(例えば杉原正泰等編集「
製剤工学ハンドツ、り」30版228ページ)等で明ら
かなとおり一次練り、二次練り等の工程があり。Plastering agents use polymers such as natural rubber or synthetic rubber, which have a relatively low water content, as a base material, but the manufacturing method of plastering agents using natural rubber or rubber materials such as styrene and isobutylene is described in the literature ( For example, edited by Masayasu Sugihara et al.
As is clear from "Pharmaceutical Engineering Hands, 30th Edition, page 228)," there are processes such as primary kneading and secondary kneading.
フランネル、不織布又はプラスチックフィルム等(バッ
キング)上へ展延する工程では溶媒を使用して展延する
か、あるいは加熱圧着して展延する等の方法が採用され
ている。このようにプラスター剤の製造方法は非常に複
雑で、多大の時間及び労力を要するものである。In the process of spreading onto flannel, nonwoven fabric, plastic film, etc. (backing), methods such as spreading using a solvent or heat-pressing are used. As described above, the method for producing plaster is very complicated and requires a great deal of time and effort.
そこで本発明者等は、上述の欠点等を有しない優れたプ
ラスター用基剤の探索について鋭意検討した結果、エチ
レン酢酸ビニル共重合樹脂が目的にかなうことを見いだ
し本発明を完成した。Therefore, the present inventors conducted extensive research to find an excellent base material for plaster that does not have the above-mentioned drawbacks, etc., and as a result found that ethylene-vinyl acetate copolymer resin met the purpose and completed the present invention.
エチレン酢酸ビニル共重合体樹脂(以下RVAと略す)
を基剤とするプラスターを製するには、初め90〜15
0℃程度に加温して基剤を溶かしたのち40〜130℃
程度に温度を維持して、各種添加剤を加えて混ぜ合わせ
れば良く。Ethylene vinyl acetate copolymer resin (hereinafter abbreviated as RVA)
To make plaster based on
After heating to around 0℃ to melt the base, 40 to 130℃
All you have to do is maintain the temperature at a moderate temperature, add various additives, and mix.
練る工程は不要であるばかりか、バッキングに展延する
場合も基剤が溶けているため、溶媒は不要であり、圧着
する必要がなく、単にパッキングの上に均一の厚みに塗
布するだけでよい。Not only is there no need for a kneading process, the base material is dissolved when spreading onto the backing, so there is no need for a solvent, and there is no need for pressure bonding, just apply it to a uniform thickness on top of the packing. .
即ち、ICVAを使用して貼付剤を製する場合繁雑な操
作は必要なく、従って誤動作が加わる心配がなく工程管
理が容易であるばかりでなく。That is, when producing a patch using ICVA, no complicated operations are required, and therefore, there is no risk of malfunction, and process control is not only easy.
布地に展延するとき流出する心配のない適度な粘弾性を
示し、かつ又皮膚への貼着性に優れたものである。It exhibits appropriate viscoelasticity so that there is no risk of leakage when spread on fabric, and also has excellent adhesion to the skin.
なお、EVAはエチレンと酢酸ビニルとの共重合樹脂で
あり、従来包装、製本、木工類の接着剤、tcはパラフ
ィン、ワ、クス、アスファルト等の改質剤、粘着用テー
プ又はシートの粘着剤として使用されうろことは公知で
あるが、貼付剤用基剤としての使用は本発明者等により
はじめて見い出されたものである。Note that EVA is a copolymer resin of ethylene and vinyl acetate, and is used as an adhesive for conventional packaging, bookbinding, and woodworking, and TC is a modifier for paraffin, wax, camphor, asphalt, etc., and an adhesive for adhesive tapes or sheets. Although scales are known to be used as adhesives, the present inventors discovered their use as a patch base for the first time.
本発明の貼付剤用基剤としてEVAを使用する場合、酢
酸ビニル含量(けん化法)15〜50 wt%でメルト
インデックス(JIS:に−6760−1966)が3
0〜5009710分であるKVAが好ましい。酢酸ビ
ニル含量が高くなると皮膚への貼着性が良くなり、融点
も低く製造しやすくなる反面酢酸臭が強くなり。When EVA is used as the base for the patch of the present invention, the vinyl acetate content (saponification method) is 15 to 50 wt% and the melt index (JIS: Ni-6760-1966) is 3.
A KVA of 0 to 5009710 minutes is preferred. The higher the vinyl acetate content, the better the adhesion to the skin, the lower the melting point, and the easier production, but the stronger the acetic acid odor.
皮膚にべとつきやすくなる0又、酢酸ビニル含量が低く
なるとKVAの結晶化度が増し、ごわごわしたものとな
り皮膚へ付きにくくなる。従って15〜5oyt%程度
のけん化度のICVAが好ましい。又、メルトインデッ
クスが大きくなると凝集力が減少し流れやすくなり延展
しにくくなると同時にベトベトして使用感が悪くなる。Also, as the vinyl acetate content decreases, the crystallinity of KVA increases, making it stiff and difficult to stick to the skin. Therefore, ICVA with a degree of saponification of about 15 to 5 oyt% is preferable. Furthermore, when the melt index increases, the cohesive force decreases, making it easy to flow and making it difficult to spread, and at the same time, it becomes sticky and has a poor feel when used.
又一方メルトインデックスが小さくなると凝集力が増大
し、皮膚への貼着性が悪くなる。従って30〜500
(g/l 0分)程度のメルトインデックスが好ましい
。On the other hand, as the melt index decreases, the cohesive force increases and the adhesion to the skin deteriorates. Therefore 30-500
A melt index of the order of (g/l 0 min) is preferred.
通常、貼付剤に特定の薬効成分を配合する場合、その成
分を溶解又は分散させる溶媒としてグリセリン、プロピ
レングリコール等のアルコール類又は流動パラフィン、
ワセリン、スクワラン等の炭化水素類、オリーブ油、大
豆・油等の油脂類、ラウリン酸、ミリスチン酸等の脂肪
酸類等が考えられるが1本発明に関しては炭化水素類が
好ましい。アルコール類、油脂類又は脂肪酸類は基剤E
VAとなじみが悪く、均一に溶解又は分散しに<<、そ
のままでは用いられず可溶化、乳化等を行わない限り、
KVAと分離してしまい使用できない。Usually, when a patch contains a specific medicinal ingredient, alcohols such as glycerin and propylene glycol or liquid paraffin are used as solvents for dissolving or dispersing the ingredient.
Hydrocarbons such as vaseline and squalane, fats and oils such as olive oil and soybean oil, and fatty acids such as lauric acid and myristic acid can be considered, but hydrocarbons are preferred in the present invention. Alcohols, fats and oils, or fatty acids are base E
It is not compatible with VA and cannot be uniformly dissolved or dispersed.
It is separated from KVA and cannot be used.
本発明の貼付剤において、添加成分等の影響により皮膚
への貼着性が十分でないときには。When the patch of the present invention does not have sufficient adhesion to the skin due to the influence of added components, etc.
ポリブテン、ポリイソブチレン、テルペン樹脂又はオレ
フィン系樹脂の粘着剤をETAに添加し、自由に貼着性
を調整することが出来る。Adhesive properties such as polybutene, polyisobutylene, terpene resin, or olefin resin can be added to ETA to freely adjust the adhesion.
製造時の布地へのなじみ又は貼付剤を使用時の皮膚への
なじみ(フィツト感又はゴワゴワした感覚)は、EVA
にジオクチルフタレート。The conformability of the patch to the fabric at the time of manufacture or the conformability to the skin (feeling of fit or stiffness) when using the patch is determined by EVA.
Dioctyl phthalate.
塩素化ハラフィン、ノニルフェニルエーテル類等の可塑
剤を加えて自由に調製することができる。It can be freely prepared by adding plasticizers such as chlorinated halafine and nonylphenyl ethers.
以下に実施例を示すが2本発明は実施例に限定されるも
のではない。実施例では消炎鎮痛剤として用いられてい
るd−カンフル、!−メントール、サリチル醗メヂル及
びハ、力油を21:24:24:81(重量比、)で混
ぜて主成分油として加えたが、これらの消炎鎮痛剤に限
定されずインドメタシン、ケトプロ7エン、ジクロフェ
ナックナトリウム又はステロイドホルモン類、ニトリグ
リセリン類、スコポラミン類等の薬物をも添加してもさ
しつかえないものである。又、バッキングとして7ラン
ネル、不織布。Examples are shown below, but the present invention is not limited to these examples. In the examples, d-camphor is used as an anti-inflammatory analgesic. - Menthol, salicylic medyl, and chili oil were mixed in a ratio of 21:24:24:81 (weight ratio) and added as the main component oil, but the anti-inflammatory and analgesic agents are not limited to these, but include indomethacin, ketopro7ene, It is also possible to add drugs such as diclofenac sodium or steroid hormones, nitriglycerin, and scopolamine. Also, 7 runnel, non-woven fabric as backing.
塩化ビニ/l/フィルム、ポリエチレンフィルム等のプ
ラスチックフィルム等を用いることができ。Plastic films such as vinyl chloride/l/film and polyethylene film can be used.
塗布量も厚み0.01w以上からできるものである。The coating amount can also be made from a thickness of 0.01w or more.
実施例1
酢酸ビニル含量45 wt%、メルトインデックス30
(9/10分)のEVA(商品名エバフレ、クス45
X)98.5部を130°Cに加熱して溶融したのち攪
拌しつつ冷却し、90℃以下になったことを確認して主
成分油(前記)1,5部を加えかきまぜつつ、綿布上に
厚みが約1鴎となるように塗布して冷却し、貼付剤を得
た。Example 1 Vinyl acetate content 45 wt%, melt index 30
(9/10 minutes) EVA (product name: Evafre, Cus 45)
X) Heat 98.5 parts to 130°C to melt it, cool it while stirring, and after confirming that the temperature is below 90°C, add 1.5 parts of the main component oil (above) and mix it with a cotton cloth. The patch was coated on top to a thickness of about 1 inch and cooled to obtain a patch.
実施例2
実施例1と同−EVA90部を130°Cに加熱して溶
かしたのち、90〜100℃に冷却し。Example 2 Same as Example 1 - 90 parts of EVA was heated to 130°C to melt it, and then cooled to 90-100°C.
あらかじめ90℃に加温した軽質流動パラフィン(日本
薬局方適合品)8.5部を加えよくかきまぜて均一に混
合したのち、攪拌しつつ冷却し。8.5 parts of light liquid paraffin (Japanese Pharmacopoeia compliant product) previously heated to 90°C was added, stirred well to mix uniformly, and then cooled while stirring.
90℃以下になったことを確認し、主成分抽1.5部を
加え、かきまぜつつ綿布上に厚みが約III@となるよ
うに塗布して冷却し、貼付剤を得た。After confirming that the temperature was below 90°C, 1.5 parts of the main component was added, and the mixture was coated on a cotton cloth to a thickness of about III@ while stirring, and cooled to obtain a patch.
実施例8
酢酸ビニル含量25 wt%、メルトインデックx+o
o(り710分)のxv*(zバフレックス810 )
60部を130℃に加熱して溶かしたのち、ポリイソブ
チレン88.5部を加えてよくかき混ぜ、均等になるま
で混合する。攪拌しつつ冷却し、90℃以下になったこ
とを確認し、主成分抽1.5部を加え、かき混ぜつつ綿
布上に厚みが約1mとなるように塗布して冷却し。Example 8 Vinyl acetate content 25 wt%, melt index x+o
o (ri 710 minutes) xv * (z buff flex 810)
After heating 60 parts to 130°C to melt, add 88.5 parts of polyisobutylene and mix well until uniform. The mixture was cooled while stirring, and after confirming that the temperature was below 90°C, 1.5 parts of the main component was added, and the mixture was coated on a cotton cloth to a thickness of about 1 m while stirring, and cooled.
貼付剤を得た。A patch was obtained.
実施例4
実施例8と同−EVA60部を1aO”Cに加熱して溶
かしたのち、ポリイソブチレン37部及びポリオキシエ
チレンノニルフェニルエーテル1.5部を加えてよくか
き混ぜて均等になるまで混合する。攪拌しつつ冷却し9
0℃以下になったことをS認し、主成分抽1.5部を加
え、かき混ぜつつ綿布上に厚みが約1mとなるように塗
布して冷却し、貼付剤を得た。Example 4 Same as Example 8 - After heating and melting 60 parts of EVA to 1aO"C, add 37 parts of polyisobutylene and 1.5 parts of polyoxyethylene nonylphenyl ether and stir well to mix until uniform. .Cool while stirring9.
After confirming that the temperature was below 0°C, 1.5 parts of the main component was added, and the mixture was coated on a cotton cloth to a thickness of about 1 m while stirring, and cooled to obtain a patch.
実施例5
実施例1と同−EVA59部を130℃に加熱して溶か
したのち、ポリブテン(平均分子量2850)10部、
軽質流動パラフィン(日本薬局方適合品)10部、テル
ペン樹脂15部及ヒホリオキシエチレンノニルフェニル
エーテル4.5部を加えてかき混ぜて均等にする。攪拌
しつつ冷却し、90°C以下になったことを確認し。Example 5 Same as Example 1 - 59 parts of EVA was heated to 130°C and melted, and then 10 parts of polybutene (average molecular weight 2850),
Add 10 parts of light liquid paraffin (product conforming to the Japanese Pharmacopoeia), 15 parts of terpene resin, and 4.5 parts of hyphoryoxyethylene nonylphenyl ether and stir to make the mixture uniform. Cool while stirring and confirm that the temperature is below 90°C.
主成分抽1.5部を加え、かき混ぜつつ綿布上に厚みが
約1鱈となるように塗布して冷却し、貼付剤を得た。1.5 parts of the main component was added, and the mixture was coated on a cotton cloth to a thickness of about 1 piece while stirring, and cooled to obtain a patch.
以上で得られた貼付剤はいずれも綿布へのなじみも良く
、皮膚への貼着性及びべとつきともに優れたものであっ
た。All of the patches obtained above blended well with cotton cloth and had excellent adhesion to the skin and stickiness.
Claims (2)
ンデックスが30〜500g/10分であるエチレン酢
酸ビニル共重合樹脂を用いることを特徴とする貼付剤。(1) A patch characterized by using an ethylene vinyl acetate copolymer resin having a vinyl acetate content of 15 to 50 wt% and a melt index of 30 to 500 g/10 minutes.
成分以上添加した特許請求の範囲第1項の貼付剤。(2) 1 part hydrocarbon such as liquid paraffin or squalane
The adhesive patch according to claim 1, in which more than one component is added.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11944084A JPS615012A (en) | 1984-06-11 | 1984-06-11 | Spreading plaster |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11944084A JPS615012A (en) | 1984-06-11 | 1984-06-11 | Spreading plaster |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS615012A true JPS615012A (en) | 1986-01-10 |
JPH0436132B2 JPH0436132B2 (en) | 1992-06-15 |
Family
ID=14761464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11944084A Granted JPS615012A (en) | 1984-06-11 | 1984-06-11 | Spreading plaster |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS615012A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2612785A1 (en) * | 1987-03-25 | 1988-09-30 | Lhd Lab Hygiene Dietetique | SELF-ADHESIVE DEVICE FOR DELIVERY OF A PERCUTANEOUS ACTIVE INGREDIENT |
WO1989007950A1 (en) * | 1988-03-04 | 1989-09-08 | Noven Pharmaceuticals, Inc. | Transdermal multipolymer drug delivery system |
JPH02300118A (en) * | 1989-05-12 | 1990-12-12 | Nitto Denko Corp | Sheet-formed transcutaneous absorption device |
JPH08508238A (en) * | 1992-09-12 | 1996-09-03 | エルテーエス ローマン テラピー ジステーム ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コムパニー コマンデイット ゲゼルシャフト | Plaster for transdermal application of steroid hormones containing dexpanthenol |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5414607A (en) * | 1977-07-06 | 1979-02-03 | Hitachi Ltd | Transfer system for time sharing signal |
JPS54117552A (en) * | 1978-03-03 | 1979-09-12 | Dai Ichi Seiyaku Co Ltd | Preparation of hydrated compound of vinyl acetate resin and poultice composition containing it |
JPS5777617A (en) * | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
JPS5883961A (en) * | 1981-11-13 | 1983-05-19 | 日東電工株式会社 | Surgical member |
JPS593965A (en) * | 1982-06-29 | 1984-01-10 | Fujitsu Ltd | Semiconductor memory device |
-
1984
- 1984-06-11 JP JP11944084A patent/JPS615012A/en active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5414607A (en) * | 1977-07-06 | 1979-02-03 | Hitachi Ltd | Transfer system for time sharing signal |
JPS54117552A (en) * | 1978-03-03 | 1979-09-12 | Dai Ichi Seiyaku Co Ltd | Preparation of hydrated compound of vinyl acetate resin and poultice composition containing it |
JPS5777617A (en) * | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
JPS5883961A (en) * | 1981-11-13 | 1983-05-19 | 日東電工株式会社 | Surgical member |
JPS593965A (en) * | 1982-06-29 | 1984-01-10 | Fujitsu Ltd | Semiconductor memory device |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2612785A1 (en) * | 1987-03-25 | 1988-09-30 | Lhd Lab Hygiene Dietetique | SELF-ADHESIVE DEVICE FOR DELIVERY OF A PERCUTANEOUS ACTIVE INGREDIENT |
US4842864A (en) * | 1987-03-25 | 1989-06-27 | Laboratories D'hygiene Et De Dietetique | Self-adhesive device for the percutaneous administration of an active ingredient |
WO1989007950A1 (en) * | 1988-03-04 | 1989-09-08 | Noven Pharmaceuticals, Inc. | Transdermal multipolymer drug delivery system |
JPH02300118A (en) * | 1989-05-12 | 1990-12-12 | Nitto Denko Corp | Sheet-formed transcutaneous absorption device |
JPH08508238A (en) * | 1992-09-12 | 1996-09-03 | エルテーエス ローマン テラピー ジステーム ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コムパニー コマンデイット ゲゼルシャフト | Plaster for transdermal application of steroid hormones containing dexpanthenol |
Also Published As
Publication number | Publication date |
---|---|
JPH0436132B2 (en) | 1992-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5243792B2 (en) | Patch | |
JP5171703B2 (en) | Medical adhesive emulsion made of ethylene-vinylacetic acid copolymer and adhesive resin | |
JPH03503283A (en) | Transdermal multipolymer drug delivery system | |
JPH04502719A (en) | pressure sensitive adhesive skin composition | |
KR20020079811A (en) | Analgesic and anti-inflammatory patches for external use containing 4-biphenylyl acetic acid | |
PL178896B1 (en) | Percutaneous matrix ssytem based on a styrene/isoperene/styrene copolymer for administration of estrogen and/or progestogen | |
CA2208374A1 (en) | Transdermal system for the simultaneous delivery of a number of active principles | |
JP2000119195A (en) | Absorption accelerator and percutaneous absorbing preparation having the same | |
JP2006206454A (en) | Plaster | |
JP5546131B2 (en) | Patch and evaluation method of patch | |
JP4625157B2 (en) | Indomethacin patch | |
JPS615012A (en) | Spreading plaster | |
JPS6340766B2 (en) | ||
JPH0336805B2 (en) | ||
JP2004121828A (en) | Skin patch drug and its base material sheet | |
JP3144895B2 (en) | Medical adhesive tape or sheet | |
JPH06199660A (en) | Patch and its production | |
JPS6034924B2 (en) | Poultice and its manufacturing method | |
JPS6034922B2 (en) | New patch medicine | |
JPS5879918A (en) | Antiphlogistic and analgesic plaster | |
JPS63203613A (en) | Hydrophilic percutaneous administration preparation | |
JP2887548B2 (en) | Hydrous skin external patch with improved usability | |
JPH0466451B2 (en) | ||
JPS61244369A (en) | Water absorbable pressure-sensitive adhesive composition | |
JPS604125A (en) | Plaster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |